NO941374L - 5-acylamino-1,2,4-tiadiazoler, fremstilling derav og farmasöytiske blandinger inneholdende dem - Google Patents

5-acylamino-1,2,4-tiadiazoler, fremstilling derav og farmasöytiske blandinger inneholdende dem

Info

Publication number
NO941374L
NO941374L NO941374A NO941374A NO941374L NO 941374 L NO941374 L NO 941374L NO 941374 A NO941374 A NO 941374A NO 941374 A NO941374 A NO 941374A NO 941374 L NO941374 L NO 941374L
Authority
NO
Norway
Prior art keywords
thiadiazoles
acylamino
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO941374A
Other languages
English (en)
Other versions
NO941374D0 (no
NO301163B1 (no
Inventor
Daniel Frehel
Daniele Gully
Robert Boigegrain
Alain Badorc
Jean-Pierre Bras
Pierre Despeyroux
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of NO941374D0 publication Critical patent/NO941374D0/no
Publication of NO941374L publication Critical patent/NO941374L/no
Publication of NO301163B1 publication Critical patent/NO301163B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO941374A 1993-04-16 1994-04-15 5-Acylamino-1,2,4-tiadiazoler, og farmasöytiske blandinger inneholdende dem NO301163B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9304535A FR2703995B1 (fr) 1993-04-16 1993-04-16 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Publications (3)

Publication Number Publication Date
NO941374D0 NO941374D0 (no) 1994-04-15
NO941374L true NO941374L (no) 1994-10-17
NO301163B1 NO301163B1 (no) 1997-09-22

Family

ID=9446163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941374A NO301163B1 (no) 1993-04-16 1994-04-15 5-Acylamino-1,2,4-tiadiazoler, og farmasöytiske blandinger inneholdende dem

Country Status (15)

Country Link
US (1) US5534530A (no)
EP (1) EP0620221A1 (no)
JP (1) JP3029372B2 (no)
CN (1) CN1050128C (no)
AU (1) AU678208B2 (no)
CA (1) CA2121425A1 (no)
FI (1) FI941776A (no)
FR (1) FR2703995B1 (no)
HU (1) HU217549B (no)
IL (1) IL109275A (no)
NO (1) NO301163B1 (no)
NZ (1) NZ260313A (no)
RU (1) RU2129550C1 (no)
TW (1) TW295584B (no)
ZA (1) ZA942577B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
DE69633196D1 (de) * 1995-10-16 2004-09-23 Fujisawa Pharmaceutical Co Heterocyclische verbindungen als h+-atpasen
NZ314105A (en) * 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
AU6659298A (en) 1997-02-18 1998-09-08 Thomas Jefferson University Compositions that bind to pancreatic cancer cells and methods of using the same
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
US6768024B1 (en) 2000-08-04 2004-07-27 Lion Bioscience Ag Triamine derivative melanocortin receptor ligands and methods of using same
EE200300161A (et) * 2000-10-26 2003-06-16 Sanofi-Synthlabo Triasooliderivaadid ja neid sisaldavad farmatseutilised kompositsioonid
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
EP1314733A1 (en) 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
WO2005012275A2 (en) 2003-03-28 2005-02-10 Janssen Pharmaceutica, N.V. Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators
AU2005289887A1 (en) * 2004-09-24 2006-04-06 Janssen Pharmaceutica, N.V. Sulfonamide compounds
US20060177438A1 (en) * 2005-02-08 2006-08-10 New England Medical Center Methods of altering absorption of hydrophobic compounds
CN102757427A (zh) * 2012-07-09 2012-10-31 陕西科技大学 2-氨基-5-异二氢吲哚-1,3-二酮甲基1,3,4-噻二唑及其制备方法
CN103601699A (zh) * 2013-11-04 2014-02-26 南京大学 一类1,3,4-噻二唑-2-酰胺衍生物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874864A (en) * 1988-05-24 1989-10-17 Pfizer Inc. Benzamide protease inhibitors
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
GB9008123D0 (en) * 1990-04-10 1990-06-06 Lilly Industries Ltd Pharmaceutical compounds
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
JPH06340663A (ja) 1994-12-13
RU2129550C1 (ru) 1999-04-27
IL109275A (en) 1998-02-08
IL109275A0 (en) 1994-07-31
CN1100724A (zh) 1995-03-29
JP3029372B2 (ja) 2000-04-04
HU9401092D0 (en) 1994-07-28
FI941776A (fi) 1994-10-17
NO941374D0 (no) 1994-04-15
NO301163B1 (no) 1997-09-22
FR2703995A1 (fr) 1994-10-21
ZA942577B (en) 1995-10-16
US5534530A (en) 1996-07-09
NZ260313A (en) 1994-12-22
FI941776A0 (fi) 1994-04-15
AU5945094A (en) 1994-10-27
HUT70542A (en) 1995-10-30
CA2121425A1 (en) 1994-10-17
CN1050128C (zh) 2000-03-08
HU217549B (hu) 2000-02-28
EP0620221A1 (fr) 1994-10-19
AU678208B2 (en) 1997-05-22
FR2703995B1 (fr) 1995-07-21
TW295584B (no) 1997-01-11

Similar Documents

Publication Publication Date Title
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
IL110793A0 (en) Benzofuran derivatives, their preparation and pharmaceutical compositions containing them
NO975985L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
IL111002A0 (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
IL110946A0 (en) 3-aryl-4-hydroxy- delta3- dihydrofuranone derivatives their preparation and pesticidal compositions containing them
IL106141A0 (en) Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them
IL101380A0 (en) Bis-naphthalimides,their preparation and pharmaceutical compositions containing them
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
NO975984L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
IL98499A0 (en) Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them
IL108636A0 (en) Polysubstitued 2-amino-thiazole derivatives, their preparation and pharmaceutical compositions containing them
IL107653A0 (en) N,n-disubstituted arylcycloalkylamines their preparation and pharmaceutical compositions containing them
IL102337A0 (en) Pyrrolpyrazines,their manufacture and pharmaceutical compositions containing them
NO941374L (no) 5-acylamino-1,2,4-tiadiazoler, fremstilling derav og farmasöytiske blandinger inneholdende dem
IL110809A0 (en) 1,5-diphenyl-3-pyrazolylalkyl-n-hydroxydithiocarbamates and pharmaceutical compositions containing them
IL103524A0 (en) Benzenesulfonamide derivatives,their preparation and pharmaceutical compositions containing them
IL110480A0 (en) Methylguanidine derivatives, their preparation and pharmaceutical compositions containing them
IL109751A0 (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
IL104042A0 (en) Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them
IL109726A0 (en) Oligomer conjugate and pharmaceutical compositions containing it
IL108632A0 (en) Fluorinated 4-aminoandrostadienone derivatives, their preparation and pharmaceutical compositions containing them
NO975365D0 (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
IL105774A (en) N-(substituted 2-pyridyl)-6-chloro-4-hydroxy-2-methyl-2h-thieno 2, 3-e9-1, 2-thiazine-3-carboxamide, 1, 1-dioxides their preparation and pharmaceutical compositions containing them
HUT70031A (en) Alfa, omega-diarylalkane derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001